The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma-Reference-Cited by-同舟云学术

The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma

Published:2018-01-15 Issue:1 Volume:15 Page:
ISSN:2045-8118
Container-title:Fluids and Barriers of the CNS
language:en
Short-container-title:Fluids Barriers CNS

Author:

Jackson Sadhana,Weingart Jon,Nduom Edjah K.,Harfi Thura T.,George Richard T.,McAreavey Dorothea,Ye Xiaobu,Anders Nicole M.,Peer Cody,Figg William D.,Gilbert Mark,Rudek Michelle A.,Grossman Stuart A.

Funder

National Center for Advancing Translational Sciences

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Developmental Neuroscience,Neurology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12987-017-0088-8.pdf

Reference39 articles.

1. Saunders NR, et al. The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system? F1000Res. 2016;5. https://doi.org/10.12688/f1000research.7378 .

2. Yang FY, et al. Pharmacokinetic analysis of 111 in-labeled liposomal doxorubicin in murine glioblastoma after blood–brain barrier disruption by focused ultrasound. PLoS ONE. 2012;7(9):e45468.

3. Doolittle ND, et al. Delivery of chemotherapeutics across the blood–brain barrier: challenges and advances. Adv Pharmacol. 2014;71:203–43.

4. Abraham T, Feng J. Evolution of brain imaging instrumentation. Semin Nucl Med. 2011;41(3):202–19.

5. Fortin D, et al. Enhanced chemotherapy delivery by intraarterial infusion and blood–brain barrier disruption in malignant brain tumors: the Sherbrooke experience. Cancer. 2005;103(12):2606–15.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Injury-like Signature of the Extracellular Glioma Metabolome;Cancers;2024-07-30

2. Engineering extracellular vesicles to permeabilize the blood-brain barrier;2024-06-26

3. Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model;Acta Neuropathologica Communications;2024-04-08

4. Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade;Current Oncology Reports;2024-02-08

5. A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension vs. Temozolomide Capsules;Pharmaceutics;2023-11-24